Overall, the use of the GLP-1 receptor agonist-SGLT-2 inhibitor combination was associated with a 30% lower risk of MACE (7.0 v 10.3 per 1000 person years
In the pituitary gland, levels of ghrelin receptor mRNA were suppressed by insulin-like growth factor-I (Kamegai et al., 2005
A detailed plan with nutrition, exercise, and mental health support sets you up for long-term success
As we move through our 30s, 40s, 50s, and beyond, preserving muscle becomes increasingly important for maintaining strength and independence
7 Similarly, a joint guideline by the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) recommends GLP-1RAs as second- or third-line therapy in patients with predominantly atherosclerotic cardiovascular disease, a compelling need to minimise hypoglycaemia or a need to promote weight loss
L., Ingram, D